Down’s Syndrome Screening
Assess the risk of chromosomal abnormalities
About Down’s Syndrome Screening
Down’s syndrome screening is a prenatal assessment designed to evaluate the likelihood of the baby having chromosomal conditions, particularly Down syndrome (Trisomy 21). It involves a combination of maternal blood tests and specialized ultrasound markers, such as the nuchal translucency measurement, performed during the first and second trimesters of pregnancy. These tests do not provide a definitive diagnosis but help identify the level of risk, allowing for further diagnostic testing if required. Early screening enables timely decision-making, appropriate medical guidance, and better pregnancy management.
Our Fertility Specialists
Expert reproductive endocrinologists dedicated to helping you achieve parenthood.
Dr. Praggya Srivastava
Chief Consultant Obstetrician, Gynecologist & Laparoscopic Surgeon
Dr. A. Shalini
Consultant fetal medicine, Obstetrics and Gynaecology
Dr. Bimal Singh
Consultant Radiologist
Dr. Divya Eluri
Consultant Obstetrician & Gynecologist
Frequently Asked Questions
Find answers to common questions about our women care services and treatments.
Does this test confirm Down’s syndrome?
No, it only shows risk. Further tests may be needed for confirmation.
What happens if the result shows high risk?
Doctors will recommend further diagnostic tests and guide you.